MiRNA-based Anti-cancer stem cell therapeutics: MiRNA-29 inhibits mammary cancer stem cell proliferation via down regulation of Wnt receptor FZD7, 02/October/2014, 16.45

MiRNA-based Anti-cancer stem cell therapeutics: MiRNA-29 inhibits mammary cancer stem cell proliferation via down regulation of Wnt receptor FZD7, 02/October/2014, 16.45

MiRNA-based Anti-cancer stem cell therapeutics: MiRNA-29 inhibits mammary cancer stem cell proliferation via down regulation of Wnt receptor FZD7, 02/October/2014, 16.45 150 150 Dr Boomi's Genom-2-Discovery Center

On the eve of Mahatma Gandhi Birth Anniversary

*********

We wish everyone a happy Mahatma Gandhi Jayanti 2014. On this special occasion, we are happy to announce that Ideas posted today (02/October/2014) will be available to the use of Scientists/Professors/Physicians/Researchers for free. So, there will be no terms and conditions for the ideas posted today (02/October/2014). Each idea posted will be served first come, first served basis. For more details, you may write to us at info@genomediscovery.org

Dr L Boominathan PhD

CEO  & CSO, GBMD

A study from the Department of Molecular Biology, Princeton University, Princeton, New Jersey 08544, USA shows that ΔNp63 promotes stem cell activity in mammary gland development and basal-like breast cancer by enhancing Fzd7 expression and Wnt signalling.”

This study was published in the September issue of 2014 Nature Cell Biology (I.F: 20.085) by Dr. Kang Y, Rumela Chakrabarti  [I.F > 20.058] and others from the Princeton University, New Jersey 08544, USA

On the foundation of this interesting finding, Dr L Boominathan, Director-cum-chief Scientist of GBMD, reports here that: MiRNA-based Anti-cancer stem cell  therapeutics: MiRNA-29 inhibits mammary cancer stem cell proliferation via down regulation of Wnt receptor FZD7 This study may suggest that MiRNA-29, by down regulating its target gene, it may inhibit the Wnt pathway. Together, this study suggests that pharmacological formulationencompassing “MiRNA-29  or its activators can be used to inhibit tumor initiating mammary cancer cells.

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, L., MiRNA-based Anti-cancer stem cell  therapeutics: MiRNA-29 inhibits mammary cancer stem cell proliferation via down regulation of Wnt receptor FZD7, 02/October/2014, 16.48, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation